Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.

Escaned, Javier; Collet, Carlos; Ryan, Nicola; Luigi De Maria, Giovanni; Walsh, Simon; Sabate, Manel; Davies, Justin; Lesiak, Maciej; Moreno, Raul; Cruz-Gonzalez, Ignacio; P Hoole, Stephan; Ej West, Nick; J Piek, J; Zaman, Azfar; Fath-Ordoubadi, Farzin; H Stables, Rodney; Appleby, Clare; van Mieghem, Nicolas; Jm van Geuns, Robert; Uren, Neal; Zueco, Javier; Buszman, Pawel; Iñiguez, Andres; Goicolea, Javier; Hildick-Smith, David; Ochala, Andrzej; Dudek, Dariusz; Hanratty, Colm; Cavalcante, Rafael; Pieter Kappetein, Arie; P Taggart, David; van Es, Gerrit-Anne; Morel, Marie-Angèle; de Vries, Ton; Onuma, Yoshinobu; Farooq, Vasim; W Serruys, Patrick; P Banning, Adrian

doi:10.1093/eurheartj/ehx512

Public

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.

Shared by NobleBlocks on Nov 7, 2017 • 12:00 AM UTC

Authors:

Javier Escaned

Carlos Collet

Nicola Ryan

Abstract

Aims: To investigate if recent technical and procedural developments in percutaneous coronary intervention (PCI) significantly influence outcomes in appropriately selected patients with three-vessel (3VD) coronary artery disease. Methods and results: The SYNTAX II study is a multicenter, all-comers,...

Subject

Coronary artery bypass graft

Drug-eluting stents

Multivessel disease

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!